Jayantha Ratnayake
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study.
Journal: The lancet. Diabetes & endocrinology
Published: November 16, 2021
Early ctDNA dynamics as a surrogate for progression-free survival in advanced breast cancer in the BEECH trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 13, 2019
A randomized, open-label study of the efficacy and safety of AZD4547 monotherapy versus paclitaxel for the treatment of advanced gastric adenocarcinoma with FGFR2 polysomy or gene amplification.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: November 28, 2017
CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study.
Journal: The Lancet. Oncology
Published: March 23, 2015
Evaluating the predictive value of biomarkers for efficacy outcomes in response to pertuzumab- and trastuzumab-based therapy: an exploratory analysis of the TRYPHAENA study.
Journal: Breast cancer research : BCR
Published: September 11, 2013
Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: May 25, 2013
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial.
Journal: The Lancet. Oncology
Published: December 14, 2011
A statistician's perspective on biomarkers in drug development.
Journal: Pharmaceutical statistics
Published: December 14, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026